| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $536K | +19.3% |
| R&D Expense | $3.6M | +18.9% |
| SG&A Expense | $2.0M | -7.1% |
| Operating Income | -$5.1M | -7.0% |
| Interest Expense | $11K | +0.0% |
| Pre-tax Income | -$5.0M | -8.6% |
| Net Income | -$5.0M | -8.6% |
| EPS (Basic) | -$4.79 | -522.1% |
| EPS (Diluted) | -$4.79 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.2M | -33.7% |
| Accounts Receivable | $85K | +162.4% |
| Current Assets | $2.6M | -23.7% |
| Total Assets | $2.7M | -25.3% |
| Current Liabilities | $754K | +95.8% |
| Total Liabilities | $754K | +74.3% |
| Stockholders' Equity | $1.9M | -39.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.0M | -25.4% |
| Capital Expenditures | $14K | +0.0% |
| Investing Cash Flow | -$14K | +0.0% |
| Financing Cash Flow | $2.8M | +112.6% |
| Free Cash Flow | -$4.0M | -25.3% |
| -522.1% |